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Figure 1: Dr. René Geronimo Favaloro (1923-2000).
This photograph was taken at a symposium held in Cleveland
sponsored by the clinic’s Thoracic & Cardiovascular Surgery
Department on November 12-13, 1992 to celebrate the 25th
anniversary of Dr. Favaloro’s  pioneering coronary artery
bypass graft at the Cleveland Clinic.
(Photo courtesy of the Cleveland Clinic Foundation.)
This project is  a follow up of the Historical Perspectives
article entitled “Memento for René Favaloro” (Captur G. Tex
Heart Inst J 2004;31:47-60) which appeared in the March
issue of the Texas Heart Institute Journal in 2004. It was the
winning essay of the 2003 Texas Heart Institute Award for
Undergraduate Writing in the History of Cardiovascular
Medicine and Surgery.
Abstract
Dr. René G. Favaloro moved to the Cleveland Clinic in 1962
and proceeded to reshape the face of  cardiac  surgery as we
knew it. Together with his colleagues at the Cleveland Clinic,
Drs. Effler, Sones, Proudfit, Groves, Sheldon and countless
others, he contributed to the double internal mammary artery-
myocardial implantation by the Vineberg method, and by May
1967, he reconstructed the right coronary artery by the
saphenous vein  graft  interposition. These landmark procedures
paved the  way for the aorto-coronary saphenous  vein bypass
graft in October 1967. Many similar breakthroughs ensued, with
the application of the bypass technique to the left coronary
artery, the combination of  coronary artery bypass graft with
left  ventricular reconstruction and valve repair/replacement
and finally, by  December, a double bypass to the  right coronary
artery and  anterior  descending branch  of  the  left coronary
artery.
In June, 1971, Dr. Favaloro decided to leave the Cleveland
Clinic and return to Argentina where he created a medical
centre, a teaching unit, a research department and finally an
Institute of Cardiology and  Cardiovascular Surgery. This was
his greatest personal ambition.
Over and  above  his brilliant  mind and craft, Dr. Favaloro
was a man of integrity,  courage, honesty and humility, whose
name will never cease to reverberate throughout the history of
medicine.
“For you to  find the  truth, in the  first  place,
you have to  believe in the  truth
with all your heart and  with  all your  soul,
and believing in the  truth
with all your heart  and  with all your  soul
means  saying  what  you  think wherever and
whenever, but  most  especially, at  the  least
opportune  moment ( ...)1”
Miguel de Unamuno
The character of Dr. Favaloro is exquisitely embodied in these
lines.
René Géronimo Favaloro (Figure 1) was born in the city of
La Plata, capital of the province of Buenos Aires, the federal
capital of the Argentine Republic. He was the grandson of Italian
immigrants: his father was a cabinet-maker; and his mother a
dressmaker.2
Dr. Favaloro received his secondary education in the famous
Colegio Nacional de La Plata, which in those days was staffed by
some of the most outstanding minds in Latin America, including
Ezequiel Martínez Estrada and Pedro Henríquez Urena.3
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Figure 2: René Favaloro (far right) together with his wife,
Maria Antonia (far left), and his parents (in the centre).
(Photo courtesy of the Favaloro Foundation.)
Figure 3: Drs. Favaloro and Effler in the Operating Room circa
1971. Dr. Effler donated this photograph to Dr. Favaloro after
the latter submitted his resignation from Cleveland Clinic in
1971. He added a dedication to the photo which read: “We have
taught each other many things”.
(Photo courtesy of the  Favaloro  Foundation,  from the Journal of
Thoracic and  Cariovascular Surgery, 58(2):178-185, Favaloro RG, with
permission from the American Association for Thoracic Surgery.)
“The University of La Plata was deeply involved in
secondary education, understanding that in this stage
of youth could be found the key and the  basis for the
moulding of the future man.4”
He graduated from high school in the upper third of his class
and then commenced his studies in the Medical Science faculty
of La Plata University2 in 1941, together with another hundred
and twenty students3. He presented his thesis and graduated at
the top of  his  class in  1948, with  the  title of Doctor  in   Medicine.
In the course of his studies Dr. Favaloro had begun to foster
a profound interest in thoracic surgery. The time was ripe for
Dr. Favaloro to develop a career as a distinguished thoracic
surgeon but the political climate which prevailed at the  time,
led him to a different path.
“After my graduation, I became a  country  doctor in the
small village of Jacinto Ar·uz in the southwest of  La
Pampas. With the help of my  younger brother, who was
also a  doctor, we turned  an  old  house into a  clinic,
which became  the  only  surgical centre in that  area.
Thousands  of patients  were  operated on during the
first 12 years of  my  practice ...I still remember the
beautiful babies  I delivered, mostly at  night, illuminated
by  a  kerosene lamp. I was following the  basic  principle
that I had  been taught at my  university- that every
graduate has a  social commitment.2”
In 1950, he married his beloved María Antonia (Figure 2) in
La Plata. She was to become his lifelong source of courage and
comfort.
Cleveland Beckons
By 1960, Dr. Favaloro began  to  cherish  the  idea of  travelling
to  the  United  States to train in thoracic and  cardiovascular
surgery. His mentor, Professor Mainetti1 , confidently
recommended Cleveland  Clinic in Ohio, so that in February
1962, Dr. Favaloro visited the clinic, accompanied  by  his  wife,
arriving  unannounced.*
At the time the Department of Thoracic Surgery consisted
of Dr. Donald B. Effler (Figure 3), and his partner, Dr. Laurence
K.Groves in addition to a senior and junior resident.5
Dr. Effler appeared willing to accept Favaloro as a
special trainee*.
“In my broken English I managed to explain the reason
for my  trip. Effler made it clear  that not  having the
proper qualifications, mainly the certificate  of the
Educational Council of Foreign Medical Graduates, I
could only be accepted as an observer, without
receiving any payment. Because I had been able  to  save
money, I pointed out that I was not asking  for  a  salary
but for  an  opportunity  to  learn.1”
From the very start, Dr. Favaloro was drawn to the work of
Dr. Mason Sones Jr. (Figure 4), and his collaborators in the
cardiac catheterisation laboratory (the famous B
10
) located in
the  basement of the  Cleveland  Clinic.6
“I spent most of my time in B
10. 
I had rented a  small
apartment across the street. Living so  close  to  the
clinic, first, spared me from travelling through the
streets and roads covered with  snow during most of
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Figure 4: Dr. Favaloro with Dr. Mason Sones Jr. Dr. Favaloro
always had a kind word for his dear friend. “…Mason Sones
being the indisputable leader. I have always thanked God for
having given me the opportunity to share my  duties  with
him.1” Dr. Favaloro visited the  Cleveland  Clinic several  times
after  his  departure; perhaps the  most important of these
trips was in 1985, when Mason Sones  was dying of
bronchogenic carcimoma.5
(Photo courtesy of the  Favaloro  Foundation,  from the Journal of
Thoracic and  Cariovascular Surgery, 58(2):178-185, Favaloro RG,
with permission from the American Association for Thoracic Surgery.)
Figure 5: The Principle of Saphenous Vein Graft Interposition.
The stitches on the anterior aspect of the anastamosis are
placed without being  tied. This  manoeuvre prevents improper
position of the  sutures.
collateral circulation from the systemic  artery implanted into
the  myocardium was  sufficient  to  increase the  myocardial
perfusion in the territory of an  occluded left anterior  descending
coronary artery.
Therefore, by 1962, myocardial revascularization had started
with both a direct approach in localised proximal obstructions
with the patch graft technique (pericardium or saphenous vein)
and also with an indirect approach with the  left  internal
mammary  artery  implant. In the light of this, Dr. Effler and the
Cleveland Clinic were very strongly motivated towards a  surgical
solution  to  coronary  artery  disease at  the  time Dr. Favaloro
joined the  team. *
Direct myocardial revascularization by the pericardial or
venous patch-graft technique9,10 was yielding good results on the
right coronary artery but not  with  left main  trunk  obstruction 11
where 11 deaths out of a total of 14 patients, was reported. 5
“In those years, I used to go to the operating room with
both the  thrill of  challenge and  fear in  my  soul.
Sometimes when the kidney transplantation team was
desperately looking for a  donor and they  saw  in the
surgical  schedule that such a  patient was  ready  to
undergo surgery once more, they  would come and  ask
permission to  perform a crossmatch before  the
operation.1”
The greatest limitation of this patch-graft technique lay  in
the coronary  artery remaining  untouched, so  that  the inner
surface  retained  irregularities that  could disturb the  flow
pattern*. The turbulence induced thrombosis and  consequent
occlusion.
“Early in 1967, I thought  that  perhaps the  problem
could  be solved  by use of  segments of  saphenous  vein.
At the Cleveland Clinic, we  had  gathered a broad
experience in peripheral and renal artery reconstruction
with that kind of  graft. Why not use  it  at  the
coronary  level?1”
the  winter in the Ohio Great Lakes  area, and second,
it allowed  me to  prolong the  review  of  the films in
the  evening and  sometimes until late  at  night.1 ”
Dr. Favaloro became a  junior  fellow in 1963 and a senior
resident  by  1964.*
Just prior to Dr. Favaloro’s arrival at the Cleveland clinic in
1962, two important events  had  already taken place. Firstly,
on 5  January 1962, Dr. Effler and his associates had  successfully
operated  on  a  severe obstruction at the  left main  coronary
artery7 using  the  patch  graft  technique  described  by Åke
Senning.8 The first patch operations were produced using a
pericardial graft to enlarge  the  lumen  of  the  left  main coronary
artery.
Secondly, on 12 January 1962, Dr. Sones examined a patient
who had been operated upon by means of  the Vineberg
procedure in Canada (first described in 1946).*  Using selective
cannulation of the left internal mammary artery he showed that
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Figure 7: Dr. Favaloro with his brother Juan José Favaloro.
Photo taken at the Sanatorium Gemes.
(Photo courtesy of the Favaloro Foundation).
Figure 6: The  Principle of  Saphenous  Vein Bypass Grafting.
The distal end-to-side anastamosis starts on the  upper  portion
from the right  coronary  artery. For the  left  coronary artery,
the  anastamosis starts  on the medial  side. Notice  that
interrupted stitches are  placed  before beginning the
anastamosis on the  distal  portion of the right  coronary artery
and proximal and distal  portions  of the left  coronary artery.
(Taken rom the Journal of  Thoracic and  Cadriovascular Surgery,
58(2):178-185, Favaloro RG, with permission from the American
Association for Thoracic Surgery).
The first such  operation was performed on 7 May, 1967 on
a 51-year-old woman and consisted of  a right coronary  artery
reconstruction by the  saphenous vein  graft  interposition12
(Figure 5).
Shortly after, the concept of aorto-coronary saphenous  vein
bypass grafting gained ground  (Figure 6). A bypass from the
anterolateral wall of the aorta to the distal end of a resected
segment of the right coronary artery, using an end-to-end
anastamosis was initially attempted in a series of patients, before
this was  changed to an end-to-side anastamosis with the
coronary distal to the blockage.5
A self-retaining  retractor, was designed by Dr. Favaloro,
during this time. With some  modifications, is  still used today
in cardiovascular  centres  all over the  world and goes by the
name of the Favaloro Retractor.5
In 1968 coronary artery bypass graft was combined with
left ventricular reconstruction (aneurysmectomy or scar tissue
resection13) and with concomitant valve repair/replacement. 14
In December of the same year, a double bypass to the right
coronary artery and LAD was  performed, thus  opening the
door  to multiple  bypass approaches in  patients  with multiple
vessel obstructions.
In 1970, Dr. Donald  Ross invited Dr Favaloro to perform
some operations  at  the National Heart  Hospital in London.1
With the  help of Dr. Ross, Dr. Favaloro in fact, carried out the
first coronary  artery  bypass in England.
‘You Chose The Easy Way’
This memorable  era, dotted with grandiose exploits, the
like of  which  few could  have envisaged in Dr. Favaloro’s life,
was just about to change:
“In 1970 I decided to return to my home country. It
was a difficult decision. I gave serious thought to this
matter and finally  considered that my  work and  my
duties were needed in Latin America. One day in
October, late in the afternoon, I wrote  my  letter  of
resignation to Effler. I closed the envelope with tears
in  my  eyes and  left it  on  his  desk. I wrote:  ‘ ...as  you
know, there is  no  real cardiovascular surgery in Buenos
Aires ... Destiny has put on  my  shoulders once  more
a  difficult task. I am going  to  dedicate the  last  one
third  of  my  life to  build  a thoracic and cardiovascular
centre in Buenos  Aires. At this particular time, the
circumstances indicate that I am the  only  one  with
the  possibility of doing  it ... Money is not the reason
for  my departure. If that would be  the  main issue, I
would take into consideration the offers  made
constantly to me from different places inside the U.S.A.
The main purpose is to develop a well-organized service
where I can train surgeons for the future. I know all the
difficulties involved because I have practised before in
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Argentina. At age 47, the logical and  realistic resolution
would  be  to remain at the Cleveland  Clinic. I know I
am taking the  difficult road. You might remember Don
Quixote was Spanish. If I do not accept the position as
Head of that department in Buenos Aires, I will be
living the rest of  my  life thinking of  myself as a  good
solid s. of a b.. My conscience would  constantly be
telling  me, ‘You chose the easy  way’.”4
Departing from the Cleveland Clinic and his beloved
colleagues there, was a momentous  task.
“My big problem was Mason. It was impossible  for  him
to accept that  I  would  break  our  common work and
brotherhood. Repeatedly he  tried to convince  me of
my ‘mistake’. The  last 3  months were  dreadful. Even
though I may  look  like  a strong and  commanding
surgeon,  deep in my  soul  I am an extremely  sensitive
fellow.”1
Staff from all over the  Cleveland Clinic, nurses and
technicians alike, beckoned him  to stay.
“Finally I decided to escape. I told everybody I was
leaving at the end of June or the beginning of July.
However, I accepted an invitation to lecture in Boston
in the middle  of  June, and from there my wife and  I
left  for Argentina ... I wrote letters to Effler and Sones.
Effler accepted my decision, which ‘avoided a painful
goodbye or farewell.’ Mason, once again, thought I was
crazy. ”1
Dr. Favaloro was welcomed warmly in Argentina as a famous
surgeon and soon became a local hero. He initially worked as
Chief of Thoracic and Cardiovascular Surgery at a hospital called
the Sanatorium Güemes, that was  a  general  surgical  clinic. Dr
Favaloro’s brother, Juan José (Figure 7), worked with him at
the Sanatorium Güemes from 1971 till 1976; the year of his death
in a  tragic accident.* After this  time Dr. Favaloro became the
surrogate  father to his brother’s four children, two of  whom
became  physicians.* Dr Favaloro and his brother, together
created the Favaloro Foundation in 1975.
His long awaited research department was made possible
in 1978.2 In 1980, Dr. Favaloro and his team carried out the
first heart transplant with long  survival in Argentina and in the
same year he also  succeeded in establishing a medical centre
and  a  teaching  unit, both  located in the Sanatorium Güemes.
Dr. Favaloro  resisted every attempt to draft him for high
political office, but instead sought to amass the funds necessary
for the construction of the Institute of Cardiology and
Cardiovascular Surgery.15 More  than ten  long years  of sacrifice,
a piece  of  land  borrowed  from the town  council, and several
loans, one  of  them  from the  International Development  Bank,
were  necessary to  finish  it.# The building was inaugurated on
the 2nd June 1992 with the motto:
“Advanced technology at the service of medical
humanism”.
 Dr. Favaloro battled all odds to create the Institute and
the results he achieved were awe-inspiring:
“At the Cleveland Clinic I always  worked on a  very
modest salary, turning down innumerable  profitable
offers from private  organizations. Approximately 25%
of the patients operated  upon in our Institute of
Cardiology and Cardiovascular Surgery in Buenos
Aires have  no insurance or  social  protection. We
provide  them  with the  same  medical assistance and
facilities as we do for everybody else.”1
By 1999, no fewer than 400 cardiologists and
cardiovascular  surgeons had  been trained in the  Favaloro
Foundation, witnesses to the enormous bravery and generosity
of this one  man.4
The Favaloro Foundation was designed to thrive upon those
ten fundamental principles which Dr. Favaloro clung to, at all
times, himself #:
1. Honesty.
2. Work with passion, effort and unlimited self-sacrifice.
3. Avoid being influenced by dogmatic concepts or prejudices
arising personally or suggested by  others.
4. An individual’s contribution will be  of  value  only if it arises
from his free will, exercised without external influences or
limitations.
5. Never stray from a  strictly ethical attitude.
6. Teamwork is  vital. This demands  humility.
7. Every action should be directed towards  the  truth and
nothing  more  than  the truth. One should speak  one’s
inner  thoughts  out  loudly. Nothing  can  be constructed
on lies.
8. If  in addition to relieving the  suffering of our  fellow-man
we  can enrich our  knowledge, then our  satisfaction will
be  doubled.
9. Our  work  is  directed  towards the patient. Consequently
he  is the only person  to  be permitted  privileges.
10. We  can  only enjoy  the accomplishment of  our work  when
we realize, preferably  in those moments of personal
reflection, that  the  only  true  prize is that gained from the
spiritual pleasure  of  a  duty  well done.#
Dr. Favaloro regularly featured on the  local media and
voiced his  opinion on matters which listeners may not have
been particularly willing to hear in the way of  social
commentary15. Despite his unorthodox Sicilian ways his
popularity blossomed relentlessly and he never ceased to
intrigue and mesmerise with his  outstanding teaching  skills.
He was an active member of the National Commission on
the Disappearance of Persons (CONADEP), which was
established after the restoration of democracy in Argentina. It
was chartered to  investigate the fates of thousands who
disappeared during the  junta rule.#
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Dr. Favaloro was nominated for and received innumerable
highly coveted accolades and international awards, and
belonged to numerous honorary and scientific  societies.
He spent his  last few years living modestly  in Buenos Aires.
And Death Will Have No Dominion
A great institution like the Favaloro Foundation required a
budget equal in greatness to maintain it. In the midst of  a good
economy this was of little concern, but in the late 1990s, when
Argentina’s economic standing turned sour, the magnitude of
the problem became all too  clear. Besides, a  subsidy  that had
been passed  by the  Argentine National Congress was
discontinued in 1998.#  At the age of 77, Dr. Favaloro was faced
with tremendous  losses due to  default in payments from
province-owned and state-owned# health insurance  programs15,
estimated at around $18 million. The  only hope of survival for
the  Favaloro  Foundation  lay in the  possibility of  making
redundant  a  sizeable  number of people, an option  which Dr.
Favaloro  flatly  rejected.#  In the last years of  his  life, at a time
when he ought to have  begun reaping the benefits  of decades
of relentless and dedicated work, he was instead compelled to
vie for additional financial help.#  He tried desperately to rectify
the situation and salvage that Foundation, which had become
his  very soul. A week before his death, he  wrote letters  to
businessmen, colleagues and to the President of Argentina#,
pleading for the  payment of government  debts to  his  institute.15
But it was to no avail.
The struggle was over. On July 29, of the year 2000, Dr.
Favaloro at the age  of 77,  died by his  own hand, according to
official reports.
News of Dr. Favaloro’s demise spread as a shock wave across
Latin America, the United States and further still. The world’s
medical community was suddenly bereft of a singular breed of
humankind that was Dr. Favaloro; it was dumbfounded and
could not come  to terms  with the  magnitude  of  such a  loss.
As a surgeon Dr. Favaloro,  will be remembered for his
ingenuity and  imagination; but as a man he will be  remembered
for  his  compassion  and  selflessnes. 16
Today  his treasured Institute in Argentina lives on; a
timeless memento to its colossal founder. After the death of Dr.
Favaloro, a new board of  directors saved the foundation through
restructuring of management, layoffs, and fund-raising.#
Although private companies initially did  not reply to the
Foundation’s request for help and De La Rúa’s government
alleged that “The Favaloro Foundation was  not  a  viable
project”, it finally succeeded to make  ends meet.# Another crisis
came with the Argentine economic default  in December 2001,
but that too passed.
Dr. Favaloro infused his passion for science, medicine and
social justice into all those who were fortunate enough to have
met him. His contributions to cardiac surgery will always bear
that extra weight because they were bestowed upon us by a giant
who had the courage to shake deep rooted systems and
brandish his fist in front of suffering.
The pulsating elixir of life which he pumped into the sickest
and most battered of hearts  will never be extinguished, but
that precious part of him which has been, shall be sorely missed
by many.
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Pharma News
Rabeprazole success in on-demand therapy
of symptomatic GORD . . .
Rabeprazole effectively controlled heartburn symptoms
in 94% of patients with moderate to very severe gastro-
oesophageal reflux disease (symptomatic but non-erosive
GORD), as shown in a recent multicentre European double
blind placebo controlled randomized trial. Moreover, the trial
has confirmed the rapid onset of action of rabeprazole
(PARIET®, Janssen-Cilag), thereby allowing 10mg to be taken
conveniently ‘on-demand’ as needed.
Long-term galantamine may reduce
need for institutionalisation in dementia . . .
A recent large, retrospective, multi-centre, international
study which included almost 600 patients, has shown that
92.5 % of patients with dementia receiving galantamine for
more than 36 months were able to stay at home for longer
periods, compared with 48-65 % of those receiving treatment
for shorter periods of time, spanning <12 months up to <36
months.  After adjustment for other risk factors for
institutionalisation, long-term treatment with galantamine
(REMINYL®, Janssen-Cilag) was associated with a 27%
relative risk reduction for institutionalisation for each
additional year of treatment.
Losartan: a wider range of tablets . . .
Losartan potassium is indicated for the treatment of
hypertension including hypertensive patients with left
ventricular hypertrophy (LVH), in whom it has been
associated with a reduced risk of stroke (although this
indication has not been proven in black patients). Losartan
also offers renal protection in type 2 diabetic patients with
nephropathy and macroalbuminuria. Losartan (COZAAR®,
MSD) is now available as 50mg and 100mg tablets. Losartan
50mg combined with hydrochlorthiazide 12.5mg (formerly
HYZAAR) is now available as COZAAR-COMP. COMP and
COZAAR are the only angiotensin II receptor blockers (ARBs)
to be indicated to reduce the risk of stroke in patients with
hypertension and LVH.
Recently introduced hormones for fertility
treatment . . .
Recombinant FSH (PUREGON®, Organon), is not derived
from urinary sources, and is indicated in the treatment of
female infertility with anovulation where controlled ovarian
hyperstimulation is required as part of an assisted
reproductive programme.
The human chorionic gonadotropin (HCG) (PREGNYL®,
Organon) induces a surge in LH and results in the release of
mature follicles. This will enhance the chances of conception
if sexual intercourse occurs or, in the case of in vitro
fertilization, if female ova are collected at this time.
Ganirelix (ORGALUTRAN®, Organon) is a potent GnRH
antagonist and is indicated for the prevention of premature
LH surges during controlled ovarian hyperstimulation.
Protelos: a breakthrough in osteoporosis
treatment . . .
The results of two large-scale phase III clinical trials have
shown that strontium ranelate (Protelos®) is effective at
reducing the risk of vertebral and hip fractures in
postmenopausal osteoporotic women, whatever the severity
of the disease and the site of fracture. Unlike bisphosphonates
and even anabolic agents, Protelos is the first agent of its kind
with a dual action on bone metabolism, simultaneously
increasing bone formation and decreasing bone resorption.
Results published in the New England Journal of Medicine
have shown that in both women with and without existing
vertebral fractures, the risk of new vertebral fractures is halved
within a year and in the longer-term. The second major
clinical study has shown that Protelos® also significantly
reduces the risk of hip fracture in postmenopausal
osteoporotic patients. PROTELOS®, Servier, was shown to
be safe, well tolerated and taken as one sachet daily.
